Fundraising FoxHepquant
1 known investors
Find your way into Hepquant
HepQuant develops noninvasive, blood-based quantitative tests that measure liver cell function and blood flow to assess liver health and disease severity. The tests are used by healthcare providers to manage patients with advanced liver disease and by drug developers in clinical trials.
Investors · 1
Frequently asked questions
- What does Hepquant do?
- HepQuant develops noninvasive, blood-based quantitative tests that measure liver cell function and blood flow to assess liver health and disease severity. The tests are used by healthcare providers to manage patients with advanced liver disease and by drug developers in clinical trials.
- Who are Hepquant's investors?
- Hepquant's investors include Colorado BioScience Association.